Clinical Trial Update: Biologic Tapering Study of TNF Inhibitors in Axial Spondyloarthritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating tapering of biologic TNF inhibitors in axial spondyloarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Snippet

Sponsor: University Health Network, Toronto | Conditions: Axial Spondyloarthritis | Phase 4 | Status: UNKNOWN